pH-activated antibiofilm strategies for controlling dental caries

Front Cell Infect Microbiol. 2023 Mar 6:13:1130506. doi: 10.3389/fcimb.2023.1130506. eCollection 2023.

Abstract

Dental biofilms are highly assembled microbial communities surrounded by an extracellular matrix, which protects the resident microbes. The microbes, including commensal bacteria and opportunistic pathogens, coexist with each other to maintain relative balance under healthy conditions. However, under hostile conditions such as sugar intake and poor oral care, biofilms can generate excessive acids. Prolonged low pH in biofilm increases proportions of acidogenic and aciduric microbes, which breaks the ecological equilibrium and finally causes dental caries. Given the complexity of oral microenvironment, controlling the acidic biofilms using antimicrobials that are activated at low pH could be a desirable approach to control dental caries. Therefore, recent researches have focused on designing novel kinds of pH-activated strategies, including pH-responsive antimicrobial agents and pH-sensitive drug delivery systems. These agents exert antibacterial properties only under low pH conditions, so they are able to disrupt acidic biofilms without breaking the neutral microenvironment and biodiversity in the mouth. The mechanisms of low pH activation are mainly based on protonation and deprotonation reactions, acids labile linkages, and H+-triggered reactive oxygen species production. This review summarized pH-activated antibiofilm strategies to control dental caries, concentrating on their effect, mechanisms of action, and biocompatibility, as well as the limitation of current research and the prospects for future study.

Keywords: Streptococcus mutans; antibiofilm agents; biofilm; dental caries; drug delivery systems; pH-responsive.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Infective Agents* / pharmacology
  • Biofilms
  • Dental Caries* / prevention & control
  • Humans
  • Hydrogen-Ion Concentration
  • Streptococcus mutans / physiology
  • Streptococcus sanguis

Substances

  • Anti-Infective Agents

Grants and funding

This study was funded by the Fujian Provincial Health Technology Project grant 2019-1-55 (XW) and Class A Open Project of Fujian Provincial Engineering Research Center of Oral Biomaterial grant 2019kq01 (LZ).